Loading, please wait ...


|  

News Analytics

97456b7166a212f0b74548cba6018e58.'
An R&D event Wednesday showcased the biotech's plans for SAGE-217, an experimental therapy central to Sage's roughly $9 billion valuation.

Subject Matter

  • Science and technology 37.97%
  • Healthcare 36.71%
    • Hospitals, doctors and medical care 100.00%
  • Business, economics, society 25.32%
    • Society and people 100.00%

Emotional Reaction

Sentiment

Positive

Neutral

Negative

Definitions
Login
Via social networks
Create Account
Via social networks